Acumen Pharmaceuticals (ABOS) Receivables - Other (2023 - 2026)
Acumen Pharmaceuticals (ABOS) posted Receivables - Other of $772000.0 for Q1 2026, up 23.52% sequentially from $625000.0 in Q4 2025, and up 105.32% YoY from $376000.0 in Q1 2025.
Acumen Pharmaceuticals (ABOS) Receivables - Other (2023 - 2026) Analysis & Trends
Acumen Pharmaceuticals has reported Receivables - Other for 4 years, with the latest figure at $772000.0 in Q1 2026.
- Quarterly Receivables - Other rose 105.32% year-over-year to $772000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $772000.0 (up 105.32% YoY) and the FY2025 annual result came in at $625000.0, up 81.16% from the prior year.
- Receivables - Other improved to $772000.0 in Q1 2026 per ABOS's latest filing, from $625000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $772000.0 in Q1 2026 and troughed at $106000.0 in Q2 2024.
- A 4-year average of $360000.0 and a median of $330000.0 in 2024 frame the typical range for Receivables - Other.
- The widest YoY moves for Receivables - Other: up 197.17% in 2025, down 41.42% in 2025.
- Over 4 years, Receivables - Other stood at $225000.0 in 2023, then surged by 53.33% to $345000.0 in 2024, then soared by 81.16% to $625000.0 in 2025, then advanced by 23.52% to $772000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $772000.0, $625000.0, and $379000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Acumen Pharmaceuticals | 232.72 Mn | 232.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 772,000.00 |
| Mar 31, 2026 | 772,000.00 |
| Dec 31, 2025 | 625,000.00 |
| Dec 31, 2025 | 625,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 315,000.00 |
| Jun 30, 2025 | 315,000.00 |
| Mar 31, 2025 | 376,000.00 |
| Mar 31, 2025 | 376,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Dec 31, 2024 | 345,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 106,000.00 |
| Jun 30, 2024 | 106,000.00 |
| Mar 31, 2024 | 189,000.00 |
| Mar 31, 2024 | 189,000.00 |